SCHEMBL25977402

SCHEMBL25977402

Cc1cc(C(=O)N(C)CCN(C)Cc2ccccc2-c2ccc3c(c2)CC(=O)N3)c(C=O)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 5/20 0.45
CACNG8 Q8WXS5 2/20 0.45
CRBN Q96SW2 1/20 0.37
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
BRD4 O60885 4/20 0.36
CREBBP Q92793 1/20 0.36
HSP90AA1 P07900 2/20 0.34
PGR P06401 3/20 0.33
FLT1 P17948 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
POLQ O75417 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
HSP90AB1 P08238 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25970414 0.88 GRIA1 (0.45) GRIA1CACNG8CRBNALOX5APFEN1
SCHEMBL24192601 0.84 HSP90AA1 (0.31) HSP90AA1
SCHEMBL24192613 0.83 CRBN (0.38) GRIA1CACNG8CRBNBRD4CREBBP
SCHEMBL24192596 0.80 GRIA1 (0.37) GRIA1CACNG8CRBNPGRPDE3B
SCHEMBL24192191 0.77 CRBN (0.38) GRIA1CACNG8CRBNBRD4HSP90AA1
SCHEMBL25970400 0.77 GRIA1 (0.33) GRIA1CACNG8CRBNPOLQ
SCHEMBL24192212 0.76 CRBN (0.36) GRIA1CACNG8CRBNBRD4CREBBP
SCHEMBL25970326 0.75 GRIA1 (0.59) GRIA1CACNG8CRBNALOX5APFEN1
SCHEMBL24192209 0.75 MAOB (0.41) CRBNPDE3BPDE3A
SCHEMBL24192731 0.74 GRIA1 (0.55) GRIA1CACNG8CRBNALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257396-A1 MACROCYCLES AND THEIR USE BLOSSOMHILL THERAPEUTICS INC (US) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257396-A1 MACROCYCLES AND THEIR USE VHL, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DLD GRIA1 4738/4885CACNG8 1780/4885CRBN 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.